GALANTAMINE SR CH galantamine (as hydrobromide) 16mg modified release capsules blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

galantamine hydrobromide, Quantity: 20.504 mg (Equivalent: galantamine, Qty 16 mg)

Disponible depuis:

Southern Cross Pharma Pty Ltd

DCI (Dénomination commune internationale):

Galantamine hydrobromide

forme pharmaceutique:

Capsule, modified release

Composition:

Excipient Ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; Gelatin; magnesium stearate; microcrystalline cellulose

Mode d'administration:

Oral

Unités en paquet:

28

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Descriptif du produit:

Visual Identification: opaque flesh-flesh size 2 hard gelatin capsule containing two round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-07-03